Evidence map›Paper›PMID 39941010›Full record

ArticleInternational journal of molecular sciences2025

Utility of Optical Genome Mapping for Accurate Detection and Fine-Mapping of Structural Variants in Elusive Rare Diseases.

Carmen Orellana, Monica Rosello, Amparo Sanchis, Laia Pedrola, Carla Martín-Grau, Alba Gabaldón-Albero, Maria Leonor Senent, Esperanza Such, Cristian García-Ruiz, Gayane Avetisyan and 1 more

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Ring chromosomes uncovered by optical genome mapping: impact of telomeric-associated regions and reference genome selection on structural variant interpretation.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carmen OrellanaGenetics Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0003-4271-5859
Monica RoselloGenetics Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0001-9234-2953
Amparo SanchisPediatrics Service, Hospital Universitario Doctor Peset, 46017 Valencia, Spain.
Laia PedrolaGenetics Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0002-3031-6124
Carla Martín-GrauTraslational Genetics Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0002-0442-819X
Alba Gabaldón-AlberoTraslational Genetics Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0009-0004-9797-5994
Maria Leonor SenentHematology and Hemotherapy Service, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Esperanza SuchHematology and Hemotherapy Service, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Cristian García-RuizHematology Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0003-2914-7914
Gayane AvetisyanHematology Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.
Francisco MartínezGenetics Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0002-0589-2584

Funding

Instituto de Salud Carlos III PI22/00272Instituto de Salud Carlos III PI22/01127
6 · The paper itself

Abstract

Rare diseases (RDs) often have a genetic basis, yet conventional diagnostic techniques fail to identify causative genetic variations in up to 50% of cases. Structural variants (SVs), including balanced rearrangements, frequently evade detection by karyotyping, microarray, and exome sequencing. The present study utilized optical genome mapping (OGM) to investigate two patients with RDs whose genetic etiology remained unresolved despite prior genomic analyses. Patient 1 exhibited a balanced reciprocal translocation disrupting the

Indexed as

Chromosome MappingGenomic Structural VariationRare DiseasesCarrier ProteinsHumansRepressor ProteinsBCL11A protein, humanCarrier ProteinsRepressor Proteinsbalanced translocationBCL11Acongenital malformationsenhancer–promoter interactionsIHHoptical genome mappingstructural variants

Identifiers

PMID39941010
PMCPMC11818634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.